Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GN-037 cream in healthy volunteers and psoriasis patients
NCT05428202Phase 1Completed
- Sponsor
- Erciyes University
- Start
- Mar 2022
- Primary completion
- Apr 2022
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GN-037 in psoriasis, sponsored by Erciyes University. Started Mar 2022; status: completed.
02
Drugs
GN-037
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT05428202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05428202.